Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/23 16:32 | 9/14/23 | NBSE | Health | Drug | Pharmaceutical Preparations | Symetryx Corp | A6 | T | S.m | -376 | 1.33 | 0 | -282 | -100 | 0 | D | |||||||||||||||
9/11/23 17:08 | 9/7/23 | NBSE | Health | Drug | Pharmaceutical Preparations | Symetryx Corp | A6 | T | S.m | -337 | 1.63 | 0 | -207 | -30 | 473 | D | |||||||||||||||
9/7/23 17:19 | 9/1/23 | NBSE | Health | Drug | Pharmaceutical Preparations | Symetryx Corp | A6 | T | P | 60 | 0.9780 | 0 | 61 | 10 | 680 | D | |||||||||||||||
8/4/23 16:39 | 8/2/23 | NBSE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | Founder, | M.d | 2 | 0.0220 | 0 | 93 | 64 | 238 | D | ||||||||||||||
2/15/23 19:30 | 2/13/23 | NBSE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | P,CEO | M.d | 0 | 0.00 | 0 | 655 | 31 | 2,746 | D | ||||||||||||||
9/30/22 19:45 | 9/28/22 | NBSE | Health | Drug | Pharmaceutical Preparations | Stephan Dietrich A | PA | DOT | CEO | M.d | 1 | 0.0011 | 0 | 750 | 56 | 2,091 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |